BioLife Solutions Inc
Audentes Therapeutics’ Promising Product Pipeline
In this series, we’ll take a look at six stocks with a focus on gene therapy that have promising products in their pipelines.
BioLife Solutions: On a Strong Footing
BioLife Solutions (BLFS) generated revenues of $5.18 million in the second quarter compared to $2.56 million in Q2 2017.
Why BioLife Solutions Stock Rose ~49% Last Week
On July 6, BioLife Solutions (BLFS) stock closed at $17.02, ~508% higher than its 52-week low of $2.80 on July 7, 2017.
Analyzing BioLife Solutions’ Target Market Dynamics
According to BioLife Solutions, the total biopreservation market is expected to reach $9.7 billion by 2024.
What Analysts Think of BioLife Solutions Stock
BioLife Solutions (BLFS) has risen from a low of $10.90 on June 28 to a high of $17.60 on July 3. BLFS closed at $16.70 on July 3.